# OnCo record aditya-bardia (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/aditya-bardia/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "aditya-bardia" ;
  schema:name "Aditya Bardia"@en ;
  schema:description "Led ASCENT, the trial that made sacituzumab govitecan the first ADC for triple-negative breast cancer, and the EMERALD trial of elacestrant."@en ;
  schema:url <https://onco.cc/people/aditya-bardia/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Bardia%20A%5BAuthor%5D%20sacituzumab%20OR%20elacestrant> ;
  onco:tag "breast", "adc", "trialist" ;
  schema:jobTitle "Professor of Medicine and Director of Translational Research Integration, UCLA Jonsson Comprehensive Cancer Center" ;
  schema:sameAs <https://orcid.org/0000-0003-4885-1157> ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/endocrine-therapy/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:targets <https://onco.cc/targets/trop2/>, <https://onco.cc/targets/estrogen-receptor/> ;
  onco:drugs <https://onco.cc/drugs/sacituzumab-govitecan/>, <https://onco.cc/drugs/datopotamab-deruxtecan/>, <https://onco.cc/drugs/elacestrant/> ;
  onco:institutions <https://onco.cc/institutions/ucla-jonsson/> ;
  onco:trials <https://onco.cc/trials/ascent/>, <https://onco.cc/trials/tropion-breast01/>, <https://onco.cc/trials/emerald/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-ascent-nejm-2021/>, <https://onco.cc/key-papers/paper-tropion-breast01-jco-2024/> ;
  schema:affiliation <https://onco.cc/institutions/ucla-jonsson/> .